News Focus
News Focus
Replies to #54609 on Biotech Values
icon url

stockdak

11/09/07 7:32 PM

#54612 RE: DewDiligence #54609

MNTA: A little knowledge is a dangerous thing...

Yes I had M118 and M-Enoxaparin confused.

Still if M-Enoxaparin is a more homogenous version of Lovenox and Lovenox has about 1% of patients with HIT response (compared to 5% for UFH) the hope is that M-Enoxaparin will be more like Arixtra which shows no HIT compared to Lovenox.

DAK